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Abstract 
We propose an integrated and adaptable approach to improve patient care and clinical outcomes through analgesia 
and light sedation, initiated early during an episode of critical illness and as a priority of care. This strategy, which may 
be regarded as an evolution of the Pain, Agitation and Delirium guidelines, is conveyed in the mnemonic eCASH—early 
Comfort using Analgesia, minimal Sedatives and maximal Humane care. eCASH aims to establish optimal patient comfort 
with minimal sedation as the default presumption for intensive care unit (ICU) patients in the absence of recognised medi‑
cal requirements for deeper sedation. Effective pain relief is the first priority for implementation of eCASH: we advocate 
flexible multimodal analgesia designed to minimise use of opioids. Sedation is secondary to pain relief and where possible 
should be based on agents that can be titrated to a prespecified target level that is subject to regular review and adjust‑
ment; routine use of benzodiazepines should be minimised. From the outset, the objective of sedation strategy is to 
eliminate the use of sedatives at the earliest medically justifiable opportunity. Effective analgesia and minimal sedation 
contribute to the larger aims of eCASH by facilitating promotion of sleep, early mobilization strategies and improved com‑
munication of patients with staff and relatives, all of which may be expected to assist rehabilitation and avoid isolation, 
confusion and possible long‑term psychological complications of an ICU stay. eCASH represents a new paradigm for 
patient‑centred care in the ICU. Some organizational challenges to the implementation of eCASH are identified.
Keywords: ICU, Pain, Analgesia, Sedation, eCASH
Introduction
Various data have indicated a consistent and strong asso-
ciation between early deep sedation and poor long-term 
outcomes, including mortality, cognitive decline and 
psychological complications [1–6]. A number of inter-
ventions have been suggested to address this [7–11], and 
a shift towards light sedation was strongly advocated in 
the Pain, Agitation and Delirium (PAD) guidelines [12] 
and the recently published German Delirium, Analgesia, 
and Sedation guidelines [13], but experience from recent 
controlled trials suggests that deep sedation continues to 
be commonplace in the intensive care unit (ICU) [14, 15].
We propose an integrated and adaptable approach to 
achieve light sedation, initiated early during an episode 
of critical illness and as a priority of care: ideally, patients 
should be comfortable, calm and able to cooperatively 
engage with caregivers and family at all times. This pro-
cess is designed to deliver effective analgesia, titrated 
goal-directed minimal sedation and a patient-centred 
focus. To that end, this strategy may be conveyed in the 
*Correspondence:  jlvincen@ulb.ac.be 
1 Department of Intensive Care, Erasme University Hospital, Université 
Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium
Full author information is available at the end of the article
Take‑home message: Excessive deep sedation, even if restricted 
to initiation of ICU treatment, is associated with worse outcome for 
ICU patients: everything should be done to avoid it. We propose a new 
approach with the acronym eCASH—early Comfort using Analgesia, 
minimal Sedatives and maximal Humane care—predicated on the early 
achievement of pain relief and the maintenance of comfort with minimal 
sedation being used to facilitate natural sleep, early mobilization and 
engagement with caregivers and relatives.
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mnemonic eCASH—early Comfort using Analgesia, 
minimal Sedatives and maximal Humane care. As illus-
trated in Fig. 1, eCASH has several distinct features:
  • An emphasis on early implementation. The time 
component of eCASH is central to the concept.
  • Generalizability: this is a sequential process-of-care 
intervention that can be delivered to all patients.
  • Promotion and facilitation of patient-centred care.
This commentary assumes prior knowledge of the 
pharmacology of sedative and analgesic agents and famil-
iarity with sedation, pain and delirium assessment scales 
and does not examine these matters in detail.
Heavy sedation: outdated but still used
Profound sedation used to be widespread in ICU 
patients, not least because the mechanical ventilation of 
the era was considered to be otherwise intolerable [16]. 
Significant improvements in ICU-related organ-support 
technology, such as advances in ventilator design, dialysis 
and extracorporeal circuits, have diminished that ration-
ale for deep sedation and the PAD guidelines have identi-
fied the possibilities for improving clinical outcomes by 
achieving and maintaining light sedation [12].
However, it is left to clinicians at the bedside to decide 
when to implement these measures. This often results in 
exactly the outcome they were meant to avoid: unneces-
sary deep sedation. This fallacy may be especially marked 
during the first few days in the ICU, when depth of seda-
tion is considered—wrongly—not to be a critical con-
sideration. In fact, observations from multiple studies 
suggest a consistent link between early deep sedation 
and significant harm [1–4], which may be attributed to a 
range of deleterious effects (Table 1).
Moderate or deep sedation remains relevant for some 
situations, including the management of severe respira-
tory failure with ventilator–patient dyssynchrony, pre-
vention of awareness in patients receiving neuromuscular 
blocking agents, status epilepticus, surgical conditions 
necessitating strict immobilization and some cases of 
severe brain injury with intracranial hypertension. For 
the vast majority of ICU patients, however, achieving and 
maintaining a light level of sedation should be sufficient 
and may avoid the potential harm caused by early overse-
dation. In this context, it should be noted that, given the 
evolution of sophisticated ventilator technologies [17], 
the response to patient–ventilator asynchrony should 
firstly be efforts to identify a more tolerable ventilator 
setting and only subsequently an increased use of anal-
gesics and/or sedatives. The ventilator should always be 
adapted to the patient, not the patient to the ventilator.
Fig. 1 The eCASH concept: early implementation to manage and prevent pain, anxiety, agitation, delirium and immobility and facilitate patient‑
centred care. (#Moderate or deep sedation remains relevant for some situations, including the management of severe respiratory failure with ven‑
tilator–patient dyssynchrony, prevention of awareness in patients receiving neuromuscular blocking agents, status epilepticus, surgical conditions 
necessitating strict immobilization and some cases of severe brain injury with intracranial hypertension)
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eCASH: a mnemonic for a modern approach
Early comfort with minimal sedation should be provided 
as a clinical priority on a par with early resuscitation, 
early sepsis management and an early lung-protective 
ventilation strategy. eCASH, with its emphasis on com-
fort, analgesia, minimal sedation and patient-centred 
care, encompasses this new outlook. Implicit in eCASH 
is the understanding that if analgesia and light seda-
tion do not achieve a calm and cooperative patient then 
the causes of failure should be identified and corrected 
before any resort to deep sedation is considered.
Pain management: the starting point for eCASH
Pain management with effective analgesia is the first pri-
ority in the implementation of the eCASH premise, and 
there is still ample scope for improvement in this area.
A systematic approach to anticipating individual 
patient requirements for analgesia is likely to improve 
pain management (Table  2). Matters for consideration 
include pre-existing chronic pain syndromes (and asso-
ciated medications) at admission and acute pain related 
to the presenting illness. During subsequent ICU care, 
analgesia is required for ongoing illness-related pain and 
discomfort related to routine treatments, such as suction 
and positioning. Intermittent increases in analgesia may 
also be required to address procedure-associated pain. 
(This requires appreciation of the pharmacokinetics of 
analgesics, especially the time-to-peak effect. Applica-
tion of a nociceptive stimulation before the peak effect of 
the drug has been reached will give the impression that 
the analgesic is ineffective.) Regular evaluation and reas-
sessment of analgesia requirements is therefore essential 
throughout the ICU stay.
In conscious, oriented patients a numeric rating scale 
(NRS) may be used to quantify pain [18]. This is not 
viable if deep sedation is used or if communication is 
impeded by brain dysfunction; for such patients, vali-
dated pain assessment scales have been developed, such 
as the Behavioral Pain Scale (BPS) and the Critical-Care 
Pain Observation Tool (CPOT) [19–21].
Opioids remain central to analgesia and the needs of 
many patients may be satisfied with low-dose opioids. 
Patient-controlled analgesia (PCA) should be preferred 
for patients who are able to use it. eCASH, however, 
emphasises the need to reduce total opioid exposure in 
order to avoid adverse effects such as respiratory depres-
sion, feeding intolerance, constipation and ileus, with-
drawal, tolerance, hyperalgesia, physical dependence and 
depression of the immune system. The use of an escalated 
multimodal strategy is recommended for that purpose 
(Fig. 2). For example, the use of paracetamol can reduce 
the overall opioid load and associated adverse effects 
[22] and is feasible even in patients with hepatic impair-
ment or injury. The introduction of adjunctive analgesics, 
such as pentins, lidocaine, alpha-2-agonists and low-dose 
ketamine, should be considered early if opioid needs are 
increasing. In the context of invasive mechanical ventila-
tion, both ketamine and the alpha-2-agonists have been 
suggested to provide an opioid-sparing effect with a 
moderate sedative effect in patients who need both anal-
gesia and sedation [23, 24].
The emphasis on low ketamine dosage is important: 
the primary aim of ketamine use in this context should 
be to provide analgesia, and this is best achieved at low 
doses. Ketamine has sedative effects at higher doses but 
there is also a dose-dependent increase in side effects, 
notably psychosis, hallucination and delirium, that make 
it unsuitable for general use as a sedative agent.
Non-pharmacological measures, including music ther-
apy and relaxation techniques, may be opioid-sparing 
and analgesia-enhancing [25]. These interventions are 
safe according to the usual meaning of that term but they 
are not a reliable low-cost option, nor are they necessarily 
easy to provide.
Sedation in eCASH
Light sedation emphasises maintaining the patient in 
a state in which they are calm, comfortable and coop-
erative (the 3C rule). Ideally, the patient can be awake in 
order to maintain eye contact, interact with caregivers 
and family members and participate in physical and/or 
occupational therapy but permitted to drift off to sleep 
Table 1 Problems potentially associated with  deep seda‑
tion
Loss of human contact
Respiratory depression
Inactivity‑induced diaphragm dysfunction
Myocardial depression and haemodynamic instability
Microvascular alterations
Altered gut function—ileus
Airway (micro)aspiration
Increased risk of pneumonia
Increased risk of thrombophlebitis
Risk of decubitus ulcers
Delirium
Risk of ICU‑acquired weakness
Peripheral muscle weakness
Immunosuppression
Prolonged mechanical ventilation/weaning
Prolonged ICU and hospital stay
Permanent cognitive deficits
Chronic psychological illnesses
Costs
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Table 2 A suggested systematic approach to assessing likely analgesia requirements to manage pain in the ICU
NB Non-steroidal anti-inflammatory agents should be used with extreme caution, if at all. Analgesic agents should only be used to achieve pain relief and not as 
sedatives. For procedural analgesia, deep sedation may be required
 PCA patient-controlled analgesia
Pain category Examples Potential therapeutic approaches Candidate drugs
Pre‑existing chronic pain or analgesia 
requirements
Chronic neuropathic pain syndromes Continue chronic pain medications  
(e.g. gabapentin, amitriptyline)
Gabapentin, amitriptyline
Opioid addiction Continue or introduce long‑acting 
agents
Methadone
Consider opioid‑sparing agents Paracetamol (acetaminophen)
Acute illness‑related pain Musculoskeletal trauma Intermittent or continuous opioid  
drugs, preferably PCA
Paracetamol (acetaminophen)
Surgery Opioid‑sparing agents Ketamine
Visceral and inflammation‑related pain Adjunct analgesics Dexmedetomidine
Analgo‑sedative agents
Continuous ICU treatment‑related  
pain/discomfort
Endotracheal tube tolerance Intermittent or continuous opioid Ketamine
Mechanical ventilation Opioid‑sparing agents Dexmedetomidine
Pressure care Analgo‑sedative agents
Physiotherapy
Joint stiffness
Intermittent procedural pain Drain insertion Boluses of opioid
Chest physiotherapy Local anaesthesia
Tracheostomy
Fig. 2 The eCASH implementation map commences upon ICU admission and focuses on coordinated effective analgesia and pain management 
and titrated minimal and light sedation. Dashed double-headed arrows identify factors and/or interventions that need to be considered concurrently. 
(#Moderate and deep sedation remains relevant for specific clinical situations, as noted in Fig. 1)
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when uninterrupted. This state, broadly equivalent to a 
Richmond Agitation Sedation Scale (RASS) score of –1/0 
[26], has been linked with favourable effects on a range of 
clinical outcomes [12].
Agitation in the critically ill patient can result from 
many factors, including pain, delirium, anxiety, drug 
withdrawal syndromes and discomfort resulting from 
poor ventilator synchrony, bowel dysfunction or pres-
sure areas. Emphasis should be placed on diagnosing 
the cause of agitation rather than simply on treating 
the symptoms, which can result in unnecessary re-
sedation. Suboptimal treatment of pain should also be 
considered as a major driver of agitation and treated 
diligently, with the emphasis on effective pain relief and 
not on masking signs of agitation. Attention must also 
be given to concomitant drivers of brain dysfunction, 
such as decreased cerebral perfusion, severe hypoxae-
mia, sepsis, high temperature, electrolyte imbalance, 
sleep disturbances and deliriogenic medications. Short-
term sedation may be required while these precipitants 
are corrected. The presence or absence of delirium 
should be objectively tested by a validated tool, such as 
the Confusion Assessment Method for the ICU (CAM-
ICU) [27].
Light or no sedation may be key to patient benefit
Successful provision of light sedation requires a combina-
tion approach with attention being paid to the choice of 
sedative agent(s) as well as targeted and titrated sedative 
intensity. These considerations have influenced a general 
retreat from benzodiazepines as first-line sedatives in the 
ICU and a move towards short-acting, easy-to-titrate 
agents such as propofol and dexmedetomidine.
A pilot study of early goal-directed sedation illustrated 
successful implementation of targeted early light seda-
tion using dexmedetom-idine as the primary sedative 
[2]. Similarly, in a study comparing sedation with dexme-
detomidine and midazolam for light sedation, sedation 
with dexmedetomidine was associated with lower rates 
of delirium, and shorter time on mechanical ventilation 
[28]. Comparative studies of propofol and dexmedetom- 
idine are equivocal [29]; either agent may therefore be 
used when targeted light sedation is required.
A ‘no-sedation’ strategy has been reported by Strøm 
et al. [11] to increase ventilator-free days, albeit with lim-
itations such as increased risk of agitation. This approach 
uses morphine and haloperidol and there has to be some 
question regarding whether this is truly a ‘no-sedative’ 
regimen or rather an opioid-based sedation strategy. 
There is in addition a widespread (though untested) belief 
that successful implementation of this approach requires 
quite a high staff:patient ratio (typically 1:1). Neverthe-
less, these concepts and approaches are consistent with 
the eCASH philosophy, some specific aspects of which 
are now examined in more detail.
Detailed examination of the pharmacology of first-line 
sedatives is beyond the scope of this discussion, but it is 
noteworthy that investigation of electroencephalography 
(EEG) patterns in patients administered different drugs 
gives substance to the view that different mechanisms of 
action may give rise to qualitatively different and distinct 
forms of sedation [30, 31].
Time to phase out benzodiazepines?
It is premature to signal the elimination of benzodiaz-
epines from the sedative repertoire but, as noted above, 
their place as first-line sedatives is greatly diminished in 
the eCASH paradigm. Non-benzodiazepine sedatives 
deliver better effects on some ‘hard’ outcomes, such as 
ICU length of stay and duration of mechanical ventila-
tion (but not short-term mortality or delirium), than 
benzodiazepines, particularly in mechanically ventilated 
patients [28, 32–35]. Benzodiazepines should be reserved 
for specific indications, such as amnesia for procedural 
sedation, convulsions, some instances of alcohol with-
drawal, intractable agitation, palliation or severe brain 
pathologies. Whether or not intermittent, titrated appli-
cation of predominantly anxiolytic gamma-aminobutyric 
acid (GABA)-agonists is beneficial is a matter of current 
research. When used, benzodiazepines should be titrated, 
preferably by intermittent rather than continuous infu-
sion, which appears to be a risk factor for delirium [36].
Goodbye daily sedation stops: hello frequent titration 
protocols
The use of bedside sedation scales may move the ICU 
team away from deep and prolonged sedation (often 
based on use of benzodiazepines) towards continu-
ous targeted light sedation with drugs that are relatively 
short-acting and easier to titrate. This will likely dimin-
ish the role and need for daily sedation stops as originally 
conceived and implemented, and is in accordance with 
the 3C principle already outlined.
Where sedation is required for optimizing patient 
care, sedative medications should be titrated to the low-
est amount required to achieve the target sedation level 
deemed necessary. The medical team should constantly 
evaluate the need for ongoing sedation and down-titrate 
sedative medications, with the explicit goal of complete 
withdrawal at the earliest clinically warranted oppor-
tunity. Sedative and analgesic drugs may accumulate 
in critically ill patients despite careful titration and use 
of short-acting agents. A stage may be reached when 
sedation stops may be needed only in cases where drug 
accumulation is suspected. There is now reasonable evi-
dence attesting to the positive impact of protocol use 
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on standards of care in analgesia, sedation and delirium 
[37–41], although not all the data are conclusive and 
affirmative [42, 43]. It should be noted that the evidence 
for protocolized therapy derives substantially from 
studies of benzodiazepines [40] and that no firm conclu-
sions on the impact of protocolization may be drawn for 
other agents. As Minhas et al. [40] have noted, explana-
tions of the benefit seen with protocolization are likely 
to involve more than simply a reduction in total sedative 
use.
Validated sedation scales at the bedside: subjective 
but valuable
Checking for excess sedation and analgesia should be 
part of a routine bedside evaluation by nurses, like 
adequate feeding, having the bed elevated or applying 
thromboembolism prophylaxis [44].
The use of clinically validated scales to monitor seda-
tion level is often recommended to facilitate targeted, 
goal-directed sedation and improve communication 
among care providers. Sedation scales rely on an interac-
tion between patient and caregiver and it may be argued 
that they lead to confirmation bias, i.e., to confirm-
ing a level of sedation already presumed to have been 
achieved. Nevertheless, they yield a quantitative estimate 
of sedation depth that can be questioned and scrutinised 
and that may be particularly useful in patients with deep 
sedative states.
The development of objective and reliable neurophysi-
ologic measures of sedation level, while proceeding at an 
experimental and proof-of-concept level, is still far from 
being a practical option at the bedside. A major prob-
lem with currently available systems, which were mostly 
designed for depth of anaesthesia monitoring, is the con-
founding effect of facial electromyography on EEG-based 
algorithms [45, 46]. The use of neurophysiologic moni-
tors should, however, be considered in patients requir-
ing deeper sedation to avoid a descent into profound 
sedation.
Patient‑centred care, a core component of eCASH
The concept of eCASH is pivotal to the delivery of 
patient-centred care for ICU patients (Table  3). A pro-
gramme that addresses all these elements should be 
implemented on ICU admission and continued through-
out the ICU stay. Close attention should be given to 
identifying and mitigating factors that obstruct the early 
introduction of eCASH.
Interdisciplinary collaboration is essential to the 
implementation and delivery of the eCASH premise. 
The team culture should focus on avoiding potentially 
harmful interventions and promoting best practice at all 
times. The role of bedside nurses and caregivers is piv-
otal within this framework, and adequate staff education 
programmes specific to sedation–analgesia manage-
ment should be a core activity and competency [47, 48]. 
Although nurse:patient ratios differ between hospitals 
and may be regarded as suboptimal in many cases, inap-
propriately deep sedation is not a defensible response to 
staff shortages. In this context, it should be noted that 
intervention consistent with the eCASH philosophy was 
associated with less use of physical restraints in the pilot 
phase of a controlled trial in mechanically ventilated, 
critically ill patients [49]. These data provide some assur-
ance that a general presumption towards light sedation 
need not be accompanied by greater need for physical 
restraints where nursing ratios are less than ideal.
Some matters for consideration are discussed in the 
next part of this commentary; additional local factors will 
apply in different ICUs.
Promotion of sleep
Many patients’ experience of sleep in an ICU is unsatis-
factory and potentially disadvantageous, and poor sleep 
has been identified in some studies as a prelude to and 
risk factor for delirium [50, 51]. Restoration of more nor-
mal sleep may become a therapeutic goal in the ICU, 
though whether that is a benefit in its own right or a sur-
rogate for other changes is difficult to determine at pre-
sent [52].
There is evidence that, beyond discomfort, sleep dep-
rivation/alteration is associated with immunodepressive 
effects that may be clinically relevant [53, 54]. These data 
provide an incentive to prevent/correct sleep disturbance 
in ICU patients, albeit that formal studies of the effects of 
correction are not available. These reflections also focus 
attention on differential effects of sedatives on immune 
function [54, 55].
Improving patient sleep can be justified as a quality-
of-care issue, with non-pharmacological methods repre-
senting a natural starting point. The deployment of ‘sleep 
bundles’—which include maintenance of regular sleep–
wake rhythms, reduction in night-time light, noise and 
Table 3 Components of patient‑centred care
Frequent and appropriate communication
Explanations of the care components
Time and space orientation
Noise reduction
Avoidance of unnecessary restraints
Sleep promotion at night
Physical activity/early mobilization
Mental stimulation
Occupational therapy including cognitive training
Family engagement
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care episodes and use of earplugs and music—may be 
helpful [25, 56, 57]. Too little is known about the effect of 
analgesics and various sedative agents on sleep patterns 
in the ICU [58]. The value of adjunct therapies, such as 
melatonin or tryptophan, is unclear [59, 60].
Early mobilization strategies
An important corollary of the eCASH strategy is that the 
patient is capable of involvement in programmes for early 
mental stimulation and physical activity. The benefits 
of early mobilization for adult ICU patients have been 
documented [61–64]; this may help to avoid agitation, 
delirium and ICU-acquired weakness and hence contrib-
utes to the eCASH paradigm [63, 64]. The risks of early 
mobilization appear to be smaller than might have been 
anticipated and the barriers to implementation, although 
impossible to ignore, are surmountable [65, 66]. It is 
therefore a matter of concern that outmoded approaches 
to sedation still appear to be a significant impediment to 
early mobilization [67, 68].
Communication with staff/relatives
Sedation strategy can significantly influence patients’ 
communication with staff/relatives. Patients’ experi-
ences of interaction with ICU staff are often brief and 
fragmented and the effects of those contacts can be 
incomprehensible, confusing or alarming to the patient 
[69]. Clearly, the capacity of a patient to communicate 
and understand is linked to alertness: to that extent, the 
adoption of eCASH-style light sedation may be expected 
to benefit the patient. Conversely, enhancement of the 
patient’s capacity to interact will benefit the patient only 
if staff are responsive to what the patient communicates 
and able to respond in a way that is coherent and com-
prehensible to the patient. Various training and technical 
measures to enhance the quality of communication have 
been proposed [70]. Good communication—an inherent 
theme of eCASH—may be expected to decrease the need 
for physical restraints.
Reorientation can be promoted through simple meas-
ures such as return of hearing aids and spectacles and 
other measures that allow patients to re-establish mean-
ingful contacts with their surroundings and with other 
people. Review of the visiting hours policy is an integral 
part of this aspect of care and rehabilitation. Attention to 
the needs of relatives is also relevant both for its effects 
on patients and as a quality improvement goal in its own 
right [71].
eCASH is about patients, their carers and families
Full realization of the goals of eCASH requires changes 
to the process and culture of care. Successful imple-
mentation of change requires a close interdisciplinary 
and interprofessional collaboration and consideration of 
the different interests and priorities of the participating 
healthcare specialists [72].
The focus must be on multimodal interventions, 
some of which will very likely fall outside the scope of 
what might usually be described as ‘medical’ [73]. Pro-
moting factors include implementation planning, train-
ing/support and effective documentation, and perhaps 
debriefing, whereas excessive staff turnover, poor staff 
morale and lack of interdisciplinary respect are obsta-
cles to implementation [72]. The development of robust 
systems to track and feed back the quality of sedation 
and analgesia provides potential methods for driving 
quality improvement in a manner similar to the suc-
cessful programmes that have decreased infections in 
ICUs [74].
Transferring responsibility and ownership of seda-
tion management to bedside staff requires appropriate 
training and education programmes within ICUs. Clear 
strategies to manage the causes of agitation are needed 
to ensure ‘buy-in’ from nursing teams, with access to sup-
port and advice for difficult cases. A supportive and ‘no-
blame’ culture in relation to the identification and review 
of sedation-related adverse events is a key element in the 
implementation of nurse-led management.
Given the variety of circumstances encountered in 
ICUs, it is not feasible to offer detailed prescriptions for 
how to implement change. By extension, it is not possible 
to make claims for how much money (if any) might be 
saved by the full and successful implementation of such 
a formula. That, however, is to miss the point: eCASH is 
a process for optimising clinical benefit to patients, both 
during their time in the ICU and potentially beyond it; 
that goal is worthwhile in its own right.
Developing eCASH
The guiding principles of eCASH are clear and com-
ponents of the eCASH concept are supported by 
current guidelines; details of this philosophy of 
care can be expected to evolve in response to clini-
cal trial data. Among trials currently in progress 
that may be expected to influence the final form of 
eCASH are: SPICE III (NCT01728558); MENDS II 
(NCT01739933); NONSEDA (NCT0196768); AWARE 
(NCT01617265); DESIRE (NCT01760967); and VITAL-
ITY (NCT02143661), which examines environmental 
influences on ICU outcomes. A longer-term goal would 
be to evaluate the clinical effectiveness of a prespecified 
eCASH bundle in a randomised clinical trial.
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